Entropy Technologies LP Has $1.61 Million Position in Henry Schein, Inc. (NASDAQ:HSIC)

Entropy Technologies LP grew its position in Henry Schein, Inc. (NASDAQ:HSIC) by 29.3% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 22,096 shares of the company’s stock after purchasing an additional 5,005 shares during the period. Entropy Technologies LP’s holdings in Henry Schein were worth $1,611,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. Cromwell Holdings LLC grew its stake in Henry Schein by 93.4% during the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after buying an additional 170 shares during the last quarter. Summit Securities Group LLC bought a new stake in Henry Schein during the 2nd quarter worth approximately $31,000. Beach Investment Counsel Inc. PA bought a new position in Henry Schein in the 2nd quarter valued at $37,000. Blue Trust Inc. boosted its stake in Henry Schein by 104.2% in the second quarter. Blue Trust Inc. now owns 931 shares of the company’s stock worth $60,000 after purchasing an additional 475 shares in the last quarter. Finally, Farther Finance Advisors LLC increased its stake in shares of Henry Schein by 58.9% in the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after buying an additional 346 shares in the last quarter. Institutional investors own 96.62% of the company’s stock.

Analyst Upgrades and Downgrades

HSIC has been the topic of several research reports. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Robert W. Baird lowered their price target on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a report on Wednesday, August 7th. UBS Group reduced their price objective on Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a report on Wednesday, August 7th. JPMorgan Chase & Co. lowered their target price on Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research note on Monday, August 12th. Finally, Barrington Research reaffirmed an “outperform” rating and set a $82.00 price target on shares of Henry Schein in a research note on Wednesday, November 6th. One analyst has rated the stock with a sell rating, six have issued a hold rating, five have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $77.50.

Insider Activity

In related news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the sale, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at approximately $4,978,026.90. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.14% of the stock is currently owned by company insiders.

Henry Schein Stock Down 1.2 %

Shares of NASDAQ HSIC opened at $67.46 on Wednesday. The firm has a 50 day moving average price of $70.40 and a 200 day moving average price of $69.63. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.90 and a current ratio of 1.42. The stock has a market cap of $8.41 billion, a P/E ratio of 27.76, a P/E/G ratio of 1.95 and a beta of 0.87. Henry Schein, Inc. has a 52-week low of $63.67 and a 52-week high of $82.63.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. During the same quarter last year, the business posted $1.32 EPS. The firm’s revenue was up .4% compared to the same quarter last year. Analysts expect that Henry Schein, Inc. will post 4.78 EPS for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.